Form 4: SeaStar Medical CFO Buys 14,500 Shares

SeaStar Medical Holding Corp's Chief Financial Officer, Michael Messinger, acquired 14,500 shares of common stock at $0.3516 per share.

Summary

• Michael Messinger, Chief Financial Officer of SeaStar Medical Holding Corp (ICU), purchased 14,500 shares of the company's common stock.
• The transaction occurred on December 9, 2025, with shares acquired at a price of $0.3516 per share.
• Following this acquisition, Mr. Messinger directly beneficially owns a total of 17,500 shares of SeaStar Medical Holding Corp common stock.
• The purchase was executed pursuant to a Rule 10b5-1(c) trading plan, indicating a pre-arranged transaction.

Sentiment

Score: 7

Explanation: The insider purchase by a key executive (CFO) is generally viewed as a positive signal, indicating management's belief in the company's value. The transaction being part of a 10b5-1 plan slightly reduces the immediate 'opportunistic' sentiment but still reflects a pre-planned positive outlook.

Positives

• A significant insider purchase by the Chief Financial Officer, Michael Messinger, acquiring 14,500 shares, which can signal management's confidence in the company's future prospects and valuation.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or the competitive landscape. However, insider buying in the medical device or biotechnology sector can sometimes be interpreted as a positive signal, especially if the company is nearing a product milestone or regulatory approval.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4) and does not contain information suitable for comparison to industry-specific operational or financial benchmarks. The transaction itself, an insider purchase, is a common occurrence across all industries.

Stakeholder Impact

• Shareholders may view the CFO's purchase as a positive indicator of management confidence, potentially influencing investor sentiment and stock valuation.

Key Dates

Recommendation

While insider buying by a CFO is a positive signal, indicating confidence in the company's future, this single transaction alone is not sufficient to warrant a 'buy' recommendation without further fundamental analysis of SeaStar Medical Holding Corp's financial health, strategic initiatives, and market position. It suggests a 'hold' for existing investors and a signal for potential investors to conduct deeper due diligence.

Keywords

SeaStar Medical, ICU, Insider Trading, Form 4, Stock Purchase, CFO, Michael Messinger, Equity Acquisition, Rule 10b5-1